 Mirati Therapeutics, Inc. NASDAQ:MRTX Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Ryan Asay - Vice President of Corporate Affairs David Meek - Chief Executive Officer Charles Baum - President, Founder Head of Research Development Laurie Stelzer - Chief Financial Officer James Christensen - Chief Scientific Officer Ben Hickey - Chief Commercial Officer Alan Sandler - Chief Medical Officer Conference Call Participants Salveen Richter - Goldman Sachs Tyler Van Buren - Cowen Gena Wang - Barclays Jonathan Miller - Evercore ISI Michael Schmidt - Guggenheim Michael Ulz - Morgan Stanley Jason Gerberry - Bank of America Maury Raycroft - Jefferies Eric Joseph - JPMorgan Benjamin Burnett - Stifel Andrew Berens - SVB Securities Yigal Nochomovitz - Citigroup Silvan Tuerkcan - JMP Securities Jay Olson - Oppenheimer Swapnil Malekar - Piper Sandler Kalpit Patel - B. Riley Securities Operator Good afternoon, and welcome to the Mirati Therapeutics Third Quarter 2022 Earnings Call. 